HRTS 股价预测及 ETF 分析 - 分红·管理费·持仓·NAV·RSI·MACD | 美股今日
详细指标表
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.75% | Return% 1Y | 17.39% | Total Holdings | 46 | Perf Week | 1.89% | Volume | 2,359 |
| Asset Type | Equities (Stocks) | AUM | $55M | Return% 3Y | - | NAV | $37.23 | Perf Month | 1.17% | Avg Volume | 0.00M |
| ETF Type | Global Equities | Dividend TTM | $0.47 (1.28%) | Return% 5Y | - | 52W High | -5.05% | Perf Quarter | 2.78% | Rel Volume | 0.62 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 15.5% | Perf Half Y | 6.54% | Prev Close | $37.23 |
| IPO | 2023/11/21 | Flows% 1M | -0.65% | Return% SI | 13.35% | RSI (14) | 55.28 | Perf YTD | 4.57% | Price | $36.90 |
| Beta | 0.65 | Flows% 3M | -0.65% | Flows% YTD | -4.35% | Flows% 1Y | -5.15% | Perf Year | 14.76% | Volatility(W/M) | 0.65% 0.74% |
| SMA20 | 1.85% | SMA50 | -0.1% | SMA200 | 4.1% | ATR | 0.46 | ||||
Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
前10大持仓占 基金的49%
按持仓比重从大到小。
过去1年中, 处于中等水平
较一年最高价低 5%。
成交量低于平时。 相当于平均成交量的62%。
长期表现为 涨跌都不大
点击查看数字
价格 波动较大
最糟糕时(2024年7月)下跌了26%,用了231天才恢复。
点击查看数字
分红 分红较少
每年可获得 1.28% 的股息。
点击查看数字
资金大量流出
最近一年流出了相当于资产5.2%的资金。
点击查看数字
常见问题
HRTS投资了多少只成分股?
HRTS共持有 46 只成分股,AUM 约为 $55M。
HRTS是否支付分红(分配)?
HRTS的分红收益率约为 1.28%。
HRTS 的 52 周最高价和最低价是多少?
HRTS 过去 52 周最高 $38.87,最低 $31.95。